-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Neutral on Chemours, Raises Price Target to $18

Benzinga·02/25/2026 16:27:01
Listen to the news
Goldman Sachs analyst Duffy Fischer maintains Chemours (NYSE:CC) with a Neutral and raises the price target from $14 to $18.